Member Info for Shareseeker10

Entered a research collaboration and option agreement with MSD (Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA) to use the MicroRx® discovery platform to develop Live Biotherapeutics in the vaccines space, including an upfront payment and potential milestone payments totalling >$1 billion

What upcoming news flow do we expect and when, surely with the tiny market cap this should move fairly quickly with the right news?

https://www.thewestonmercury.co.uk/news/outbreak-of-coronavirus-at-weston-general-hospital-1-6669079

Can you imagine what will happen when the schools go back......

https://www.thewestonmercury.co.uk/news/outbreak-of-coronavirus-at-weston-general-hospital-1-6669079

Testing could go on for many many years even if we find a vaccine, people are more cautious & skeptical than ever before about a quick to market vaccine. The anti vaccine movement is already big in Central Europe and very big in USA.

https://www.google.com/amp/s/www.businessinsider.com/coronavirus-vaccine-only-55-percent-americans-would-get-immunized-survey-2020-5%3famp

In monkeys and only 25......

https://www.telegraph.co.uk/news/2020/05/24/second-wave-covid-uk-coronavirus-winter/

Yes agree it has to be far enough away from normal mm day to day variation. Mines at 1.30p.

I fully expect £2.30 very soon WITHOUT NEWS and multiples on expected or better than expected news. Zak Mir says £2.30 based on current chart very soon.

Simple, hold and set a sensible stop loss, that way you protect capital but are exposed to the upcoming gains....We have a month of 3 or maybe 4 potential RNS, I have a stop loss at 1.30 and holding the rest until mid summer then review, in from 45p and been buying up to 140p

How will they get funding to develop and market the product? Would any future placing in Stem Print impact TILS ?

As soon as lock downs ease this will just keep coming back....test test test

https://www.bloomberg.com/news/articles/2020-05-21/why-a-new-virus-cluster-in-china-is-triggering-alarms-quicktake?utm_content=business&utm_source=twitter&utm_medium=social&cmpid=socialflow-twitter-business&utm_campaign=socialflow-organic

July is only 6 weeks away, global interest will really kick off in 3 or 4 weeks....The key thing is that it will be the best on the market, obviously we all want it now but testing will last for years so a few more weeks is fine. Sir Al might even be under promising on timing.....

Zak charts is at £2.30 in the short term, obviously RNS will blow that. This is what all holders are here for the flurry of RNS between now and July to take us towards £1bn market cap

Read Myles Twitter rationale which is only based on a conservative portion of the rapid test market.

Sir Al has been very bullish on the accuracy & quality. Cost is very important and ours is the cheapest.

I think not only do we have the speed and quality advantage but also through Boohoo profile, marketing and distribution we’ll be the mass market option. Yes some of these other tests will be used until we are mass producing in mid summer however cream rises and the 1hour and 75 minute tests with big and clunky hardware will become obsolete and we’ll take full control.

I think AVCT are more focused on the massive US market hence the Cytiva partnership.

The test have to be quick and cheap, that’s where AVCT are, take airports for example, already full of bottlenecks, the last thing they need is a 75 minute test ! Be the time you’ve got the result you could have caught it again waiting around with hundreds of people.....a quick test keeps the process flowing

Thank mytton

Do ORR have a good management team? I’m impressed by the asset base vs. market cap.

How much skin do they have in the game ?